Evidence map›Paper›PMID 40299786›Full record

ArticleCancer research2025

Eco-Evolutionary Guided Pathomic Analysis Detects Biomarkers to Predict Ductal Carcinoma In Situ Upstaging.

Yujie Xiao, Manal Elmasry, Ji Dong K Bai, Andrew Chen, Yuzhu Chen, Brooke Jackson, Joseph O Johnson, Prateek Prasanna, Chao Chen, Mehdi Damaghi

Abstract read
In one paragraph

Article in Cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Metabolic starvation-induced cell swelling drives solid stress in tumors.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Yujie XiaoDepartment of Applied Mathematics and Statistics, Stony Brook University, New York, New York.ORCID 0000-0003-3179-4387
Manal ElmasryDepartment of Pathology, Stony Brook Medicine, Stony Brook University, New York, New York.ORCID 0000-0001-8125-5790
Ji Dong K BaiDepartment of Pathology, Stony Brook Medicine, Stony Brook University, New York, New York.ORCID 0000-0001-5543-7427
Andrew ChenDepartment of Pathology, Stony Brook Medicine, Stony Brook University, New York, New York.ORCID 0009-0001-8752-8822
Yuzhu ChenDepartment of Pathology, Stony Brook Medicine, Stony Brook University, New York, New York.ORCID 0009-0007-5402-3629
Brooke JacksonMoffitt Cancer Center, Tampa, Florida.ORCID 0009-0006-2294-862X
Joseph O JohnsonMoffitt Cancer Center, Tampa, Florida.ORCID 0000-0001-8574-6909
Prateek PrasannaDepartment of Biomedical Informatics, Stony Brook Medicine, Stony Brook University, New York, New York.ORCID 0000-0002-3068-3573
Chao ChenDepartment of Biomedical Informatics, Stony Brook Medicine, Stony Brook University, New York, New York.ORCID 0000-0003-1703-6483
Mehdi DamaghiDepartment of Applied Mathematics and Statistics, Stony Brook University, New York, New York.ORCID 0000-0002-7744-6161

Funding

Radiomics and Pathomics to predict upstaging of DCISR01CA249016 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI DAMAGHI, MEHDI, NIELL, BETHANY LYNN · 2021 to 2025
$3.4M
Ecology and Evolution of Breast CarcinogenesisU01CA261841 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI DAMAGHI, MEHDI, SIQUEIRA SILVA, ARIOSTO S · 2021 to 2025
$3.0M
Modeling the role and regulation of reactive stroma in breast ductal carcinoma microinvasionsR01CA272601 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI DAMAGHI, MEHDI, REJNIAK, KATARZYNA ANNA · 2022 to 2025
$2.9M
SCH: Topological Methods for Breast Tissue QuantificationR01CA297843 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI Chao Chen, Prateek Prasanna · 2024 to 2026
$900k
National Institute of General Medical Sciences (NIGMS) R01GM148970National Institutes of Health (NIH) R01CA249016National Institutes of Health (NIH) R01CA272601National Institutes of Health (NIH) R01CA297843National Institutes of Health (NIH) R21CA258493-02S1National Institutes of Health (NIH) U01CA261841NCI NIH HHS R01 CA249016NCI NIH HHS R01 CA272601NCI NIH HHS R01 CA297843NCI NIH HHS U01 CA261841
6 · The paper itself

Abstract

Cancers evolve in a dynamic ecosystem. Thus, characterizing the ecological dynamics of cancer is crucial to understanding cancer evolution, which can lead to the discovery of biomarkers to predict disease progression. Ductal carcinoma in situ (DCIS) is an early-stage breast cancer characterized by abnormal epithelial cell growth confined within the milk ducts, and biomarkers are needed to predict which cases will progress to aggressive disease. In this study, we showed that ecological analysis of hypoxia and acidosis biomarkers can significantly improve prediction of DCIS upstaging. Quantitative analyses were performed on immunohistologic images from a retrospective cohort of DCIS specimens collected from biopsy samples. First, an eco-evolutionary designed approach was developed to define habitats in the tumor intraductal microenvironment based on oxygen diffusion distance. Then, cancer cells with metabolic phenotypes attributed to their habitats were identified, including a hypoxia-responding CA9+ phenotype and an acid-adapted LAMP2b+ phenotype. Whereas these markers have traditionally shown limited, if any, predictive capabilities for DCIS progression when analyzed from an ecological perspective, their power to differentiate between non-upstaged and upstaged DCIS increased significantly. Additionally, the distribution of distinct niches with specific spatial patterns of these biomarkers predicted patient upstaging. The niches were characterized by pattern analysis of both cellular and spatial features. A random forest classifier that was trained and underwent a five-fold validation on the biopsy cohort achieved an AUC of 0.74 for predicting clinical outcome. These results affirm the importance of tumor ecological features in eco-evolutionary-designed approaches for biomarker discovery. SIGNIFICANCE: Evolutionary dynamics of the various niches composing the tumor ecosystem can be harnessed for predicting cancer progression, demonstrating how eco-evolutionary-designed approaches can guide biomarkers discovery studies in the era of digital pathology. This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI.

Indexed as

Biomarkers, TumorBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingDisease ProgressionFemaleHumansMiddle AgedNeoplasm StagingPrognosisRetrospective StudiesTumor MicroenvironmentBiomarkers, Tumor

Identifiers

PMID40299786
PMCPMC13289847

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.